SUNPHARMAPharmaceuticals
Sun Pharmaceutical Industries Ltd — Balance Sheet
₹1757.20
+0.66%
Sun Pharmaceutical Industries Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 239.93 Cr | 239.93 Cr | 239.93 Cr | 239.93 Cr | — |
| Share Issued | 239.93 Cr | 239.93 Cr | 239.93 Cr | 239.93 Cr | — |
| Total Debt | 2.36K Cr | 3.27K Cr | 6.89K Cr | 1.29K Cr | — |
| Tangible Book Value | 54.26K Cr | 46.36K Cr | 38.31K Cr | 35.43K Cr | — |
| Invested Capital | 74.09K Cr | 66.51K Cr | 62.19K Cr | 48.94K Cr | — |
| Working Capital | 34.43K Cr | 26.49K Cr | 19.98K Cr | 17.81K Cr | — |
| Net Tangible Assets | 54.26K Cr | 46.36K Cr | 38.31K Cr | 35.43K Cr | — |
| Capital Lease Obligations | 492.56 Cr | 427.98 Cr | 687.99 Cr | 359.61 Cr | — |
| Common Stock Equity | 72.22K Cr | 63.67K Cr | 56.00K Cr | 48.01K Cr | — |
| Total Capitalization | 72.22K Cr | 63.67K Cr | 56.00K Cr | 48.24K Cr | — |
| Total Equity Gross Minority Interest | 72.49K Cr | 67.13K Cr | 59.32K Cr | 51.07K Cr | — |
| Minority Interest | 267.93 Cr | 3.46K Cr | 3.32K Cr | 3.05K Cr | — |
| Stockholders Equity | 72.22K Cr | 63.67K Cr | 56.00K Cr | 48.01K Cr | — |
| Other Equity Interest | 71.98K Cr | 63.43K Cr | 55.76K Cr | 47.77K Cr | — |
| Retained Earnings | 57.86K Cr | 50.15K Cr | 43.61K Cr | 37.65K Cr | — |
| Additional Paid In Capital | 1.19K Cr | 1.19K Cr | 1.19K Cr | 1.19K Cr | — |
| Capital Stock | 239.93 Cr | 239.93 Cr | 239.93 Cr | 239.93 Cr | — |
| Common Stock | 239.93 Cr | 239.93 Cr | 239.93 Cr | 239.93 Cr | — |
| Total Liabilities Net Minority Interest | 19.61K Cr | 18.37K Cr | 21.43K Cr | 18.73K Cr | — |
| Total Non Current Liabilities Net Minority Interest | 1.42K Cr | 1.39K Cr | 1.52K Cr | 1.53K Cr | — |
| Other Non Current Liabilities | 19.18 Cr | 11.20 Cr | 12.95 Cr | 15.70 Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | 453.46 Cr | 399.72 Cr | 326.19 Cr | 343.35 Cr | — |
| Tradeand Other Payables Non Current | 8.76 Cr | — | — | — | — |
| Non Current Deferred Revenue | 376.74 Cr | 488.74 Cr | 569.87 Cr | 618.75 Cr | — |
| Non Current Deferred Taxes Liabilities | 192.44 Cr | 171.86 Cr | 31.69 Cr | 31.86 Cr | — |
| Long Term Debt And Capital Lease Obligation | 358.26 Cr | 303.62 Cr | 559.91 Cr | 481.71 Cr | — |
| Long Term Capital Lease Obligation | 355.74 Cr | 302.29 Cr | 559.91 Cr | 251.79 Cr | — |
| Long Term Debt | 2.52 Cr | 1.33 Cr | 0.00 | 229.92 Cr | — |
| Long Term Provisions | 11.58 Cr | 14.17 Cr | 16.72 Cr | 25.72 Cr | — |
| Current Liabilities | 18.19K Cr | 16.98K Cr | 19.91K Cr | 17.20K Cr | — |
| Other Current Liabilities | 1.04K Cr | 957.92 Cr | 486.00 Cr | 510.38 Cr | — |
| Current Deferred Taxes Liabilities | 733.18 Cr | 411.70 Cr | 308.71 Cr | — | 179.08 Cr |
| Current Debt And Capital Lease Obligation | 2.00K Cr | 2.97K Cr | 6.33K Cr | 808.59 Cr | — |
| Current Capital Lease Obligation | 136.82 Cr | 125.69 Cr | 128.08 Cr | 107.82 Cr | — |
| Current Debt | 1.87K Cr | 2.84K Cr | 6.20K Cr | 700.77 Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 718.64 Cr | 683.19 Cr | 470.27 Cr | 427.33 Cr | — |
| Current Provisions | 5.44K Cr | 4.67K Cr | 4.88K Cr | 8.72K Cr | — |
| Payables | 8.04K Cr | 7.03K Cr | 7.04K Cr | 6.32K Cr | — |
| Other Payable | 1.84K Cr | 1.37K Cr | 1.35K Cr | 1.66K Cr | — |
| Dividends Payable | 14.91 Cr | 11.35 Cr | 10.43 Cr | 10.09 Cr | — |
| Total Tax Payable | 733.18 Cr | 411.70 Cr | 308.71 Cr | 178.14 Cr | — |
| Accounts Payable | 6.18K Cr | 5.65K Cr | 5.68K Cr | 4.48K Cr | — |
| Total Assets | 92.10K Cr | 85.50K Cr | 80.74K Cr | 69.80K Cr | — |
| Total Non Current Assets | 39.48K Cr | 42.02K Cr | 40.86K Cr | 34.78K Cr | — |
| Other Non Current Assets | 540.12 Cr | 473.93 Cr | 5.16K Cr | -0.10 Cr | — |
| Non Current Prepaid Assets | 796.80 Cr | 2.62K Cr | 2.63K Cr | 2.77K Cr | — |
| Non Current Deferred Taxes Assets | 4.41K Cr | 4.10K Cr | 3.52K Cr | 2.90K Cr | — |
| Investmentin Financial Assets | 4.37K Cr | 6.06K Cr | 5.15K Cr | 4.99K Cr | — |
| Available For Sale Securities | 3.95K Cr | 5.39K Cr | 4.54K Cr | 4.07K Cr | — |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 425.44 Cr | 671.49 Cr | 607.47 Cr | 922.57 Cr | — |
| Long Term Equity Investment | 448.73 Cr | 442.61 Cr | 383.64 Cr | 266.08 Cr | — |
| Investmentsin Joint Venturesat Cost | 47.29 Cr | 36.48 Cr | 36.16 Cr | 34.02 Cr | — |
| Investmentsin Associatesat Cost | 401.44 Cr | 406.13 Cr | 347.48 Cr | 232.06 Cr | — |
| Goodwill And Other Intangible Assets | 17.96K Cr | 17.30K Cr | 17.68K Cr | 12.58K Cr | — |
| Other Intangible Assets | 9.02K Cr | 8.73K Cr | 9.33K Cr | 6.03K Cr | — |
| Goodwill | 8.94K Cr | 8.57K Cr | 8.36K Cr | 6.55K Cr | — |
| Net PPE | 11.49K Cr | 11.49K Cr | 11.48K Cr | 11.26K Cr | — |
| Accumulated Depreciation | -13.57K Cr | -12.58K Cr | -11.62K Cr | -10.04K Cr | — |
| Gross PPE | 25.06K Cr | 24.06K Cr | 23.11K Cr | 21.30K Cr | — |
| Construction In Progress | 1.45K Cr | 1.30K Cr | 1.09K Cr | 888.36 Cr | — |
| Other Properties | 10.04K Cr | 10.19K Cr | 10.39K Cr | 10.37K Cr | — |
| Machinery Furniture Equipment | 15.54K Cr | 14.92K Cr | 14.30K Cr | 13.50K Cr | — |
| Buildings And Improvements | 7.05K Cr | 6.80K Cr | 6.82K Cr | 6.05K Cr | — |
| Land And Improvements | 1.02K Cr | 1.05K Cr | 897.84 Cr | 862.12 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 52.62K Cr | 43.47K Cr | 39.88K Cr | 35.01K Cr | — |
| Other Current Assets | 73.35 Cr | 64.67 Cr | 86.25 Cr | 54.09 Cr | — |
| Hedging Assets Current | 65.25 Cr | 34.95 Cr | 20.23 Cr | 92.74 Cr | — |
| Assets Held For Sale Current | 30.41 Cr | 41.87 Cr | 21.40 Cr | — | — |
| Restricted Cash | 20.00 Cr | 15.16 Cr | 12.89 Cr | 12.50 Cr | — |
| Prepaid Assets | 2.85K Cr | 2.79K Cr | 2.33K Cr | 2.12K Cr | — |
| Inventory | 10.24K Cr | 9.87K Cr | 10.51K Cr | 9.00K Cr | — |
| Finished Goods | 4.57K Cr | 4.58K Cr | 4.41K Cr | 3.90K Cr | — |
| Work In Process | 2.02K Cr | 2.01K Cr | 2.50K Cr | 2.06K Cr | — |
| Raw Materials | 3.65K Cr | 3.28K Cr | 3.61K Cr | 3.04K Cr | — |
| Other Receivables | -20.73 Cr | 80.13 Cr | 42.41 Cr | 495.53 Cr | — |
| Accounts Receivable | 13.05K Cr | 11.25K Cr | 11.44K Cr | 10.59K Cr | — |
| Allowance For Doubtful Accounts Receivable | -326.20 Cr | -405.81 Cr | -414.93 Cr | -368.56 Cr | — |
| Gross Accounts Receivable | 13.37K Cr | 11.66K Cr | 11.85K Cr | 10.96K Cr | — |
| Cash Cash Equivalents And Short Term Investments | 26.32K Cr | 19.33K Cr | 15.41K Cr | 12.65K Cr | — |
| Other Short Term Investments | 16.05K Cr | 10.04K Cr | 10.79K Cr | 8.15K Cr | — |
| Cash And Cash Equivalents | 10.27K Cr | 9.29K Cr | 4.62K Cr | 4.51K Cr | — |
| Cash Equivalents | 6.97K Cr | 6.84K Cr | 1.39K Cr | 2.34K Cr | — |
| Cash Financial | 3.30K Cr | 2.44K Cr | 3.24K Cr | 2.16K Cr | — |
| Treasury Shares Number | — | 0.00 | — | — | — |
| Derivative Product Liabilities | — | 0.00 | 3.79 Cr | 16.00 Cr | 19.24 Cr |
| Financial Assets | — | 0.00 | 0.01 Cr | 0.55 Cr | 0.20 Cr |
| Net Debt | — | — | 1.57K Cr | — | — |
| Liabilities Heldfor Sale Non Current | — | — | 0.62 Cr | — | — |
| Other Investments | — | — | — | 684.67 Cr | 947.24 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Sun Pharmaceutical Industries Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.